Wells Fargo & Company Roivant Sciences Ltd. Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Wells Fargo & Company holds 7,501 shares of ROIV stock, worth $84,686. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,501
Previous 4,075
84.07%
Holding current value
$84,686
Previous $47,000
87.23%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ROIV
# of Institutions
324Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$743 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$701 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$540 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$498 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$399 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.95B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...